Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Teva: $30 Or $0 - Legal Risks Offer Setup For A Strangle Or Straddle
05:14pm, Tuesday, 25'th May 2021
Without legal risks, Teva would be a compelling long, with ~200% upside potential if the company can meet 2023 targets, which I think is possible. However, legal risks, particularly the lack of a nati
The Top 5 Trades of Francisco Garcia Parames' Firm
02:05pm, Friday, 07'th May 2021
Francisco Garcia Parames (Trades, Portfolio), founder and leader of Spanish investment firm Cobas Asset Management, disclosed his first-quarter portfolio earlier this week.
Domino's, Editas, Roblox, Teva, US Steel and More Tuesday Afternoon Analyst Calls
12:16pm, Tuesday, 04'th May 2021
With the trading day more than halfway over, the broad markets were getting crushed.
TEVA Stock: From $10.12 To $10.64 Explanation
10:54pm, Thursday, 29'th Apr 2021
The stock price of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) increased 5.09% as it went from $10.12 to $10.64. This is why it happened.
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its launch of the first avail
TEVA Beats on Q1 Earnings and Sales, Keeps View, Stock Down
08:16am, Thursday, 29'th Apr 2021
TEVA beats on first-quarter earnings and sales. Sales & profits decline year over year.
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q1 2021 Results - Earnings Call Transcript
02:32pm, Wednesday, 28'th Apr 2021
Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q1 2021 Results - Earnings Call Transcript
Major COVID-19 Vaccine Makers Reject Teva Pharmaceutical's Offer For Jab Manufacture Help: FT
02:29pm, Wednesday, 28'th Apr 2021
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) CEO said that its offers to help manufacture coronavirus vaccines were turned down by major vaccine makers, despite having production capacity ready
What's Behind Teva's Mixed Q1 Results
10:55am, Wednesday, 28'th Apr 2021
Increased competition for several of its top products continued to affect the drugmaker's performance in Q1.
Exclusive: Teva Pharm unlikely to reach deals to co-produce vaccines -CEO
10:10am, Wednesday, 28'th Apr 2021
Israel's Teva Pharmaceutical Industries is not likely to reach deals with COVID vaccine makers to co-produce the vaccines although discussions are still ongoing, chief executive Kare Schultz told Reut
Teva's stock gains after it beats earnings expectations
07:40am, Wednesday, 28'th Apr 2021
Shares of Teva Pharmaceutical Industries Ltd. gained 0.6% in premarket trading after the drug maker beat earnings expectations for the first quarter, even though sales of its multiple-sclerosis drug c
J&J, other drugmakers go to trial in California in $50 billion case over 'deadly legacy' of opioids
06:39pm, Monday, 19'th Apr 2021
Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at th
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
09:09am, Wednesday, 14'th Apr 2021
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate)
03:00am, Thursday, 08'th Apr 2021
AMSTERDAM--(BUSINESS WIRE)--Teva Pharmaceuticals Europe announced that it has received EU Marketing Authorisation for Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/ fluti
Abercrombie, Pfizer, Teva and More of Wednesday Afternoon Analyst Calls
11:45am, Wednesday, 07'th Apr 2021
With the trading day approaching halfway over, the broad markets were trading marginally positive.
